Browse > Article

The Consequences of Mutations in the Reproductive Endocrine System  

Choi, Donchan (Dept. of Life Science, College of Environmental Sciences, Yong-In University)
Publication Information
Development and Reproduction / v.16, no.4, 2012 , pp. 235-251 More about this Journal
Abstract
The reproductive activity in male mammals is well known to be regulated by the hypothalamus-pituitary-gonad axis. The hypothalamic neurons secreting gonadotropin releasing hormone (GnRH) govern the reproductive neuroendocrine system by integrating all the exogenous information impinging on themselves. The GnRH synthesized and released from the hypothalamus arrives at the anterior pituitary through the portal vessels, provoking the production of the gonadotropins(follicle-stimulating hormone (FSH) and luteinizing hormone (LH)) at the same time. The gonadotropins affect the gonads to promote spermatogenesis and to secret testosterone. Testosterone acts on the GnRH neurons by a feedback loop through the circulatory system, resulting in the balance of all the hormones by regulating reproductive activities. These hormones exert their effects by acting on their own receptors, which are included in the signal transduction pathways as well. Unexpected aberrants are arised during this course of action of each hormone. This review summarizes these abnormal phenomena, including various mutations of molecules and their actions related to the reproductive function.
Keywords
Reproduction; Hypothalamus-pituitary-gonad axis; Mutation; Mammal;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG, Charlton HM (2000) The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 141:1795-1803.   DOI   ScienceOn
2 Achard C, Courtillot C, Lahuna O, Méduri G, Soufir JC, Lière P, Bachelot A, Benyounes H, Schumacher M, Kuttenn F, Touraine P, Misrahi M (2009) Normal spermatogenesis in a man with mutant luteinizing hormone. N Engl J Med 361:1856-1863.   DOI   ScienceOn
3 Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, de la Chapelle A (1996) Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 81:3722-3726.   DOI
4 Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR, Nieschlag E, Huhtaniemi I, de la Chapelle A (1995) Mutation in the folliclestimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82:959-968.   DOI   ScienceOn
5 Arnhold IJ, Lofrano-Porto A, Latronico AC (2009) Inactivating mutations of luteinizing hormone beta subunit or luteinizing hormone receptor cause oligoamenorrhea and infertility in women. Horm Res 71:75-82.
6 Auger J, Faugeron I, Larue L, Lumbroso S, Themmen APN, Bouchard P (2008) A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister. Human Reprod 23:1917-1923.   DOI   ScienceOn
7 Baker PJ, Pakarinen P, Huhtaniemi IT, Abel MH, Charlton HM, Kumar TR, O'Shaughnessy PJ (2003) Failure of normal Leydig cell development in follicle-stimulating hormone (FSH) receptor deficient mice, but not FSH beta-deficient mice: role for constitutive FSH receptor activity. Endocrinology 144:138-145.   DOI   ScienceOn
8 Bardin CW, Bullock L, Schneider G, Allison JE, Stanley AJ (1970) Pseudohermaphrodite rat: end organ insensitivity to testosterone. Science 167:1136-1137.   DOI   ScienceOn
9 Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, Matzuk MM (1999) Transgenic models to study gonadotropin function: the role of folliclestimulating hormone in gonadal growth and tumorigenesis. Molecular Endocrinology 13:851-865.   DOI   ScienceOn
10 Kumar TR, Wang Y, Lu N, Matzuk MM (1997) Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15:201-204.
11 La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79.   DOI   ScienceOn
12 Laue L, Chan WY, Hsueh AJ, Kudo M, Hsu SY, Wu SM, Blomberg L, Cutler GB, Jr (1995) Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male limited precocious puberty. Proc Nat'l Acad Sci USA 92:1906-1910.   DOI   ScienceOn
13 Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, Millasseau P, Le Paslier D, Cohen D, Caterina D, Bougueleret L, Delemarre-Van de Waal H, Lutfalla G, Weissenbach J, Petit C, (1991) The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67:423-435.   DOI   ScienceOn
14 Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S, Bick DP, Sherins RR, Duck LW, Musgrove LC, Sellers JC, Neill JD (1998) Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet 18:14-15.   DOI   ScienceOn
15 Layman LC, Lee EJ, Peak DB, Namnoum AB, Vu KV, van Lingen BL, Gray MR, McDonough PG, Reindollar RH, Jameson JL (1997) Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med 337:607-611.   DOI   ScienceOn
16 Leanos-Miranda A, Janovick JA, Conn PM (2002) Receptormisrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4825-4828.   DOI   ScienceOn
17 Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X, Rao CV (2001) Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 15:184-200.   DOI   ScienceOn
18 Gromoll J, Simoni M, Nieschlag E (1996) An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 81:1367-1370.   DOI
19 Hardelin JP, Dode C (2008) The complex genetics of Kallman syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2:181-193.   DOI   ScienceOn
20 Hardelin JP, Julliard AK, Moniot B, Soussi-Yanicostas N, Verney C, Chwanzel-Fukuda M, Ayer-Le Lievre C, Petit C (1999) Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev Dyn 215:26-44.   DOI   ScienceOn
21 Haywood M, Spaliviero J, Jimemez M, King NJ, Handelsman DJ, Allan CM (2003) Sertoli and germ cell development in hypogonadal (hpg) mice expressing transgenic follicle-stimulating hormone alone or in combination with testosterone. Endocrinology 144:509-517.   DOI   ScienceOn
22 Kumar TR (2007) Functional analysis of LH beta knockout mice. Mol Cell Endocrinol 269:81-84.   DOI   ScienceOn
23 Huhtaniemi I (2000) Mutations of gonadotrophin and gonadotrophin receptor genes: what do they teach us about reproductive physiology? J Reprod Fertil 119:173-186.
24 Kendall SK, Gordon DF, Birkmeier TS, Petrey D, Sarapura VD, O'Shea KS, Wood WM, Lloyd RV, Ridgway EC, Camper SA (1994) Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol 8:1420-1433.   DOI   ScienceOn
25 Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, Grootegoed JA Themmen AP (1995) A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 80:3168-3172.   DOI
26 Goldstein JL, Wilson JD (1972) Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization. J Clin Invest 51:1647-1658.   DOI
27 Griffin JE (1992) Androgen resistance-the clinical and molecular spectrum. N Engl J Med 326:611-618.   DOI   ScienceOn
28 Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P, Brown CJ, Willard HF, Lawrence C, Graziella Persico M, Camerino G, Ballabio A (1991) A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal pathfinding molecules. Nature 353:529-536.   DOI   ScienceOn
29 Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P, Brown CJ, Willard HF, Lawrence C, Graziella Persico M, Camerino G, Ballabio A (1991) A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal pathfinding molecules. Nature 353:529-536.   DOI   ScienceOn
30 Beau I, Tourraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F, Misrahi M (1998) A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 102:1352-1359.   DOI   ScienceOn
31 Galway AB, Hsueh AJ, Daneshdoost L, Zhou MH, Pavlou SN, Snyder PJ (1990) Gonadotroph adenomas in men produce biologically active follicle stimulating hormone. J Clin Endocrinol Metab 71:907-912.   DOI
32 Goglia U, Vinanzi C, Zuccarello D, Malpassi D, Ameri P, Casu M, Minuto F, Foresta C, Ferone D (2011) Identification of a novel mutation in exon 1 of androgen receptor gene in an azoospermic patient with mild androgen insensitivity syndrome: case report and literature review. Fertil Steril 2011 96:1165-1169.
33 Gerasimova T, Thanasoula MN, Zattas D, Seli E, Sakkas D, Lalioti MD (2010) Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH. J Clin Endocrinol Metab 95:529-536.   DOI   ScienceOn
34 Ghadessy FJ, Lim J, Abdullah AAR, Panet-Raymond V, Choo CK, Lumbroso R, Tut TG, Gottlieb B, Pinsky L, Trifiro MA, Yong EL (1999) Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J Clin Invest 103:1517-1525.   DOI   ScienceOn
35 Giwercman A, Kledal T, Schwartz M, Giwercman YL, Leffers H, Zazzi H, Wedell A, Skakkebaek NE (2000) Preserved male fertility despite decreased androgen sensitivity caused by a mutation in the ligand-binding domain of the androgen receptor gene. J Clin Endocrinol Metab 85:2253-2259.   DOI   ScienceOn
36 Cheung LW, Wong AS (2008) Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues. FEBS J 275:5479-5495.   DOI   ScienceOn
37 Chu J, Zhang R, Zhao Z, Zou W, Han Y, Qi Q, Zhang H, Wang JC, Tao S, Liu X, Luo Z (2002) Male fertility is compatible with an Arg840Cys substitution in the AR in a large Chinese family affected with divergent phenotypes of AR insensitivity syndrome. Clin Endocrinol Metab 87:347-351.   DOI   ScienceOn
38 Clarke IJ, Cummins JT (1984) Direct pituitary effects of estrogen and progesterone on gonadotropin secretion in the ovariectomized ewe. Neuroendocrinology 39:267-274.   DOI
39 Clarke IJ, Cummins JT, de Kretser DM (1983) Pituitary gland function after disconnection from direct hypothalamic influences in the sheep. Neuroendocrinology 36:376-384.   DOI
40 Costa EM, Bedecarrats GY, Mendonca BB, Arnhold IJ, Kaiser UB, Latronico AC (2001) Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J Clin Endocrinol Metab 86:2680-2686.   DOI   ScienceOn
41 Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP (2003) Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33:463-465.   DOI   ScienceOn
42 de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972-10976.   DOI   ScienceOn
43 de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E (1997) A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 337:1597-1602.   DOI   ScienceOn
44 Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P (1998) Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95:13612-13617.   DOI   ScienceOn
45 Fichna P, Fichna M, Zurawek M, Nowak N (2011) Hypogonadotropic hypogonadism due to GnRH receptor mutation in a sibling. Pol J Endocrinol 62:264-267.
46 Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkman AO (1998) Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Mol Endocrinol 12:1172-1183.   DOI   ScienceOn
47 Binder H, Strick R, Zaherdoust O, Dittrich R, Hamori M, Beckmann MW, Oppelt PG (2012) Assessment of FSHR variants and anti-Müllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. Fertil Steril 97:1169-1175.   DOI   ScienceOn
48 Bliss SP, Navratil AM, Xie J, Roberson MS (2010) GnRH signaling, the gonadotrope and endocrine control of fertility. Neuroendocrinology 31:322-340.   DOI   ScienceOn
49 Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lombes M, Millar RP, Guiochon-Mantel A, Young J (2009) Isolated familial hypogonadotropic hypogonadism and a GnRH1 mutation. N Engl J Med 360:2742-2748.   DOI   ScienceOn
50 Bremner WJ, Millar MR, Sharpe RM, Saunders PT (1994) Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. Endocrinology 135:1227-1234.   DOI   ScienceOn
51 Bedecarrats GY, Kaiser UB (2007) Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function. Semin Reprod Med 25:368-378.   DOI   ScienceOn
52 Bedecarrats GY, Linher KD, Janovick JA, Beranova M, Kada F, Seminara SB, Michael CP, Kaiser UB (2003a) Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function. Mol Cell Endocrinol 205:51-64.   DOI   ScienceOn
53 Bedecarrats GY, Linher KD, Kaiser UB (2003b) Two common naturally occurring mutations in the human gonadotropin-releasing hormone (GnRH) receptor have differential effects on gonadotropin gene expression and on GnRH-mediated signal transduction. J Clin Endocrinol Metab 88:834-843.   DOI   ScienceOn
54 Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E (1978) Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropinreleasing hormone. Science 202:631-633.   DOI   ScienceOn
55 Beranova M, Oliveira LM, Bedecarrats GY, Schipani E, Vallejo M, Ammini AC, Quintos JB, Hall JE, Martin KA, Hayes FJ, Pitteloud N, Kaiser UB, Crowley WF Jr, Seminara SB (2001) Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutation in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 86:1580-1588.   DOI   ScienceOn
56 Berger K, Souza H, Brito VN, d'Alva CB, Mendonca BB, Latronico AC (2005) Clinical and hormonal features of selective follicle-stimulating hormone (FSH) deficiency due to FSH beta-subunit gene mutations in both sexes. Fertil Steril 83:466-470.   DOI   ScienceOn
57 Ligtenberg MJ, Siers M, Themmen AP, Hanselaar TG, Willemsen W, Brunner HG (1999) Analysis of mutations in genes of the follicle stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. J Clin Endocrinol Metab 84:2233-2234.   DOI
58 Lim J, Ghadessy FJ, Abdullah AAR, Pinsky L, Trifiro M, Yong EL (2000) Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor). Mol Endocrinol 14:1187-1197.   DOI   ScienceOn
59 Liu G, Duranteau L, Carel J-C, Monroe J, Doyle DA, Shenker A (1999) Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341:1731-1736.   DOI   ScienceOn
60 Lindstedt G, Nystrom E, Matthews C, Ernest I, Janson PO, Chatterjee K (1998) Follitropin (FSH) deficiency in an infertile male due to FSHbeta gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin Chem Lab Med 36:663-665.
61 Lyon MF, Hawkes SG (1970) X-linked gene for testicular feminization in the mouse. Nature 227:1217-1219.   DOI   ScienceOn
62 Ma X, Dong Y, Matzuk MM, Kumar TR (2004) Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility. Proc Natl Acad Sci USA 101:17294-17299.   DOI   ScienceOn
63 Marshall JC, Kelch RP (1986) Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction. N Engl J Med 315:1459-1468.   DOI   ScienceOn
64 Martens JWM, Verhoef-Post M, Abelin N, Ezabella M, Toledo SPA, Brunner HG, Themmen APN (1998) A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: Correlation between receptor activity and phenotype. Molecular Endocrinol 12:775-784.   DOI   ScienceOn
65 Mason AJ, Hayflick JS, Zoeller RT, Young WS III, Phillips HS, Nikolics K, Seeburg PH (1986a) A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 234:1366-1371.   DOI
66 Mason AJ, Pitts SL, Nikolics K, Szonyi E, Wilcox JN, Seeburg PH, Stewart TA (1986b) The hypogonadal mouse: reproductive functions restored by gene therapy. Science 234:1372-1378.   DOI
67 Matsumoto T, Takeyama K, Sato T, Kato S (2003) Androgen receptor functions from reverse genetic models. J Steroid Biochem Mol Biol 85:95-99.   DOI   ScienceOn
68 Matthews C, Chatterjee VK (1997) Isolated deficiency of follicle stimulating hormone re-revisited. N Engl J Med 337:642.
69 Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A, Chatterjee VK (1993) Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nature Genetics 5:83-86.   DOI   ScienceOn
70 Petaja-Repo UE, Hogue M, Laperriere A, Bhalla S, Walker P, Bouvier M (2001) Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, degly-cosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276:4416-4423.   DOI   ScienceOn
71 Pettersson K, Makela MM, Dahlen P, Lamminen T, Huoponen K, Huhtaniemi I (1994) Genetic polymorphism found in the LH beta gene of an immunologically anomalous variant of human luteinizing hormone. Europ J Endocrinol 130(Suppl) 2:65.
72 McPhaul MJ (1999) Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol 69:315-322.   DOI   ScienceOn
73 Miura K, Acierno JS Jr, Seminara SB (2004) Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). J Hum Genet 49:265-268.   DOI   ScienceOn
74 Phillip M, Arbelle JE, Segev Y, Parvari R (1998) Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med 338:1729-1732.   DOI   ScienceOn
75 Nilsson C, Jiang M, Pettersson K, Iitia A, Makela M, Simonsen H, Easteal S, Herrera RJ, Huhtaniemi I (1998) Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol (Oxford) 49:369-376.   DOI   ScienceOn
76 Nishimura R, Shin J, Ji I, Middaugh CR, Kruggel W, Lewis RV, Ji TH (1986) A single amino acid substitution in an ectopic alpha subunit of a human carcinoma choriogonadotropin. J Biol Chem 261:10475-10477.
77 Okuda K, Yamada T, Imoto H, Komatsubara H, Sugimoto O (1994) Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions. Biochem Biophys Res Comm 200:584-590.   DOI   ScienceOn
78 Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321.
79 Rao CV (1996) The beginning of a new era in reproductive biology and medicine: expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in non-gonadal tissues. J Physiol Pharmacol 47(Suppl) 1:41-53.
80 Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, Cole LW, Pearce SH, Lee H, Boepple P, Crowley WF Jr, Pitteloud N (2007) Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 357:863-873.   DOI   ScienceOn
81 Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH (1995) Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 92:1322-1326.   DOI   ScienceOn
82 Romero Y, Meikar O, Papaioannou MD, Conne B, Grey C, Weier M, Pralong F, De Massy B, Kaessmann H, Vassalli J-D, Kotaja N, Nef S (2011) Dicer1 depletion in male germ cells leads to infertility due to cumulative meiotic and spermiogenic defects. PLoS ONE 6:e25241.   DOI
83 Sar M, Lubahn DB, French FS, Wilson EM (1990) Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127:3180-3186.   DOI   ScienceOn
84 Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770-774.   DOI   ScienceOn
85 Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH (2003) The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614-1627.   DOI   ScienceOn
86 Semple RK, Topaloglu AK (2010) The recent genetics of hypogonadotropic hypogonadism-novel insights and new questions. Clin Endcorniol (Oxford) 72:427-435.   DOI   ScienceOn
87 Shenker A, Laue L, Kosugi S, Merendino JJ, Jr, Minegishi T, Cutler GB Jr (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654.   DOI   ScienceOn
88 Singh J, Handelsman DJ (1996) The effects of recombinant FSH on testosterone-induced spermatogenesis in gonadotrophin-deficient (hpg) mice. J Androl 17:382-393.
89 Simoni M, Gromoll J, Höppner W, Kamischke A, Krafft T, Stahle D, Nieschlag E (1999) Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 84:751-755.   DOI   ScienceOn
90 Simoni M, Gromoll J, Nieschlag E (1997) The folliclestimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Rev 18:739-773.   DOI   ScienceOn
91 Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT (1997) Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nature Genetics 15:205-206.   DOI   ScienceOn
92 Themmen APN, Huhtaniemi IT (2000) Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21:551-583.   DOI   ScienceOn
93 Topaloglu AK, Lu ZL, Farooqi IS, Mungan NO, Yuksel B, O'Rahilly S, Millar RP (2006) Molecular genetic analysis of normosmic hypogonadotropic hypogonadism in a Turkish population: identification and detailed functional characterization of a novel mutation in the gonadotropin-releasing hormone receptor gene. Neuroendocrinolgy 84:301-308.
94 Tsutsumi R, Webster NJ (2009) GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J 56:729-737.   DOI   ScienceOn
95 Vornberger W, Prins G, Musto NA, Suarez-Quian CA (1994) Androgen receptor distribution in rat testis: new implications for androgen regulation of spermatogenesis. Endocrinology 134:2307-2316.   DOI   ScienceOn
96 Wang Q, Ghadessy FJ, Trounson A, de Kretser D, McLachlan R, Ng SC, Yong EL (1998) Azoospermia associated with a mutation in the ligand binding domain of an androgen receptor displaying normal ligand binding, but defective transactivation. J Clin Endocrinol Metab 83:4303-4309.   DOI
97 Wang R-S, Yeh S, Tzeng C-R, Chang C (2009) Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocr Rev 30:119-132.   DOI   ScienceOn
98 Wintermantel TM, Campbell RE, Porteous R, Bock D, Grone HJ, Todman MG, Korach KS, Greiner E, Perez CA, Schutz G, Herbison AE (2006) Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52:271-280.   DOI   ScienceOn
99 Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL (1992) Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med 326:179-183.   DOI   ScienceOn
100 Wintermantel TM, Campbell RE, Porteous R, Bock D, Grone HJ, Todman MG, Korach KS, Greiner E, Perez CA, Schutz G, Herbison AE (2006) Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52:271-280.   DOI   ScienceOn
101 Yong EL, Ng SC, Roy AC, Yun G, Ratnam SS (1994) Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene. Lancet 344:826-827.   DOI   ScienceOn
102 Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C (2002) Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503.   DOI   ScienceOn
103 Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I (2001) Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 15:172-183.   DOI   ScienceOn